Health

Johnson & Johnson’s two-dose Ebola vaccine regimen produces a strong immune response in both children and adults, according to EU-funded researchers.

Scientists know that a subset of genes are linked to familial breast cancer. However, this link has yet to be clearly determined or ruled out for many newly emerging genes. The FBC predisposition project aims to clear up remaining doubts.

Clinical data obtained from 120 000 people will soon help women across Europe assess their lifetime risk of developing breast cancer. The BRIDGES project used this data to develop a tool able to combine various risk factors into a single risk-score.

Researchers studied over 10 000 Capsicum annuum pepper samples from gene banks worldwide to gain insight into the history of this common food.

How will the COVID-19 pandemic progress in the next few months and years? Researchers conducted an expert survey to determine the main aspects likely to influence the pandemic in Europe.

According to a new study, when undergoing immunotherapy, cancer patients with human leukocyte antigen class I (HLA I) variants that bind to a wide range of peptides have worse survival rates.

A new study sheds light on the role of genetic risk factors and the cells involved in the development of coronary artery disease (CAD).

Nanosized shells made of DNA can trap viruses, rendering them harmless.

Do Europeans really wash their hands after handling raw chicken? An EU-backed study takes a closer look at five European countries’ hygiene practices in the kitchen.

A new study has tested the immune response of people who received a second vaccination with BioNTech-Pfizer after their first Oxford-AstraZeneca shot. The results are promising.

Preliminary results of a clinical trial for Crigler-Najjar syndrome point to gene therapy as a potential alternative treatment for this life-threatening liver disease.

Taking its name from the so-called Fourth Industrial Revolution, the BEYOND4.0 project has set itself the task of providing research-based advice for policymakers and stakeholders on the impact, challenges and opportunities of rapidly advancing digital technologies in relation to the future of work and welfare.

Scientists have identified different immune responses in people with COVID-19 ranging from asymptomatic to critically ill.

Even a highly transmissible SARS-CoV-2 variant can be beat. According to an Israeli study, proactive monitoring combined with prioritised vaccination can drastically reduce transmission of the B.1.1.7 variant as well as consequent severe illness and death in the elderly.

EU-backed scientists have presented a chemical compound that could lead to drugs that prevent SARS-CoV-2 infection.

Addressing inequalities in urban and peri-urban contexts is at the heart of the UPLIFT project. This is particularly relevant as social and economic inequalities have been growing in most wealthy countries in recent decades, even more so since the 2008-2009 financial crisis. With a focus on vulnerable youth, the project aims to develop a Reflexive Policy Agenda through participatory co-creation that will hopefully lead to more flexible, adaptive policies.

What really happens when SARS-CoV-2 infects human cells? German and Swiss scientists have investigated the functions and interactions of the viral proteins, providing a comprehensive profile of coronavirus infection at the molecular level.

A CE mark has been awarded to a non-invasive imaging device that promises to lighten the burden of inflammatory bowel disease (IBD) sufferers.

There’s new hope for patients with large bone defects. Scientists have developed a biomaterial that can help repair bone defects, defying the body’s natural capacity to heal.

EU-backed scientists show us how smart materials called magnetoactive polymers (MAPs) could someday be used to stimulate healing in epithelial wounds.